{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:45:28Z","timestamp":1782301528062,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejca.2022.12.012","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T02:14:13Z","timestamp":1672107253000},"page":"145-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-1226","authenticated-orcid":false,"given":"Rainer","family":"Hamacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0092-5233","authenticated-orcid":false,"given":"Xiaofei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-1049","authenticated-orcid":false,"given":"Markus K.","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopold","family":"Hentschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sch\u00f6ffski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Georg","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8425-8356","authenticated-orcid":false,"given":"Bernd","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-8264","authenticated-orcid":false,"given":"Lars","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Markus","family":"Chemnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Crysandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9768-0086","authenticated-orcid":false,"given":"Alexander","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlinde","family":"Egerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2862-7302","authenticated-orcid":false,"given":"Philipp","family":"Ivanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annegret","family":"Kunitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"30","key":"10.1016\/j.ejca.2022.12.012_bib1","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1200\/JCO.20.00714","article-title":"Randomized comparison of pazopanib and doxorubicin as first-line treatment in patients with metastatic soft tissue sarcoma age 60 Years or older: results of a German intergroup study","volume":"38","author":"Gr\u00fcnwald","year":"2020","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2022.12.012_bib2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14740338.2021.1915985","article-title":"Managing the risk of toxicity in the treatment of elderly patients with soft tissue sarcomas","volume":"20","author":"Arifi","year":"2021","journal-title":"Expet Opin Drug Saf"},{"issue":"26s","key":"10.1016\/j.ejca.2022.12.012_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2217\/fon-2019-0489","article-title":"Sarcomas and old age: few options for such a large patient population","volume":"15","author":"Jones","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.ejca.2022.12.012_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103108","article-title":"The challenge of treating elderly patients with advanced bone and soft tissue sarcomas","volume":"155","author":"Kasper","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"10.1016\/j.ejca.2022.12.012_bib5","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0959-8049(99)00152-5","article-title":"Epidemiological aspects of soft tissue sarcomas (STS)--consequences for the design of clinical STS trials","volume":"35","author":"Nijhuis","year":"1999","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2022.12.012_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12889-018-5131-4","article-title":"Strengthening health data on a rare and heterogeneous disease: sarcoma incidence and histological subtypes in Germany","volume":"18","author":"Ressing","year":"2018","journal-title":"BMC Publ Health"},{"issue":"7","key":"10.1016\/j.ejca.2022.12.012_bib7","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/annonc\/mdt059","article-title":"Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival","volume":"24","author":"Garbay","year":"2013","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2022.12.012_bib8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1634\/theoncologist.2017-0598","article-title":"Outcomes of elderly patients with advanced soft tissue sarcoma treated with first-line chemotherapy: a pooled analysis of 12 EORTC soft tissue and bone sarcoma group trials","volume":"23","author":"Younger","year":"2018","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.ejca.2022.12.012_bib9","article-title":"The role of the comprehensive geriatric assessment in the evaluation of the older cancer patient","volume":"33","author":"Blanquicett","year":"2019","journal-title":"Oncology (Williston Park)"},{"issue":"6","key":"10.1016\/j.ejca.2022.12.012_bib10","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","article-title":"The prevalence and outcomes of frailty in older cancer patients: a systematic review","volume":"26","author":"Handforth","year":"2015","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2022.12.012_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2021.4158","article-title":"Geriatric assessment-driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial","volume":"7","author":"Li","year":"2021","journal-title":"JAMA Oncol"},{"issue":"10314","key":"10.1016\/j.ejca.2022.12.012_bib12","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","article-title":"Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study","volume":"398","author":"Mohile","year":"2021","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ejca.2022.12.012_bib13","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.21.00195","article-title":"Understanding treatment tolerability in older adults with cancer","volume":"39","author":"Flannery","year":"2021","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2022.12.012_bib14","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/annonc\/mdq687","article-title":"EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors","volume":"22","author":"Pallis","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2022.12.012_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","article-title":"Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)","volume":"55","author":"Extermann","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8","key":"10.1016\/j.ejca.2022.12.012_bib16","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","article-title":"Screening older cancer patients: first evaluation of the G-8 geriatric screening tool","volume":"23","author":"Bellera","year":"2012","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2022.12.012_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"issue":"12","key":"10.1016\/j.ejca.2022.12.012_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115060","article-title":"Screening for vulnerability in older cancer patients: the ONCODAGE prospective multicenter cohort study","volume":"9","author":"Soubeyran","year":"2014","journal-title":"PLoS One"},{"issue":"15_suppl","key":"10.1016\/j.ejca.2022.12.012_bib19","doi-asserted-by":"crossref","first-page":"20568","DOI":"10.1200\/jco.2008.26.15_suppl.20568","article-title":"Validation of a screening test for elderly patients in oncology","volume":"26","author":"Soubeyran","year":"2008","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2022.12.012_bib20","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/cncr.25538","article-title":"Trends in survival for patients with metastatic soft-tissue sarcoma","volume":"117","author":"Italiano","year":"2011","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2022.12.012_bib21","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/cncr.23332","article-title":"Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients","volume":"112","author":"Karavasilis","year":"2008","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2022.12.012_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1200\/JCO.1999.17.1.150","volume":"17","author":"Van Glabbeke","year":"1999","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2022.12.012_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jgo.2019.05.008","article-title":"Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial","volume":"11","author":"Younger","year":"2020","journal-title":"J Geriatr Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.12.012_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jgo.2016.11.002","article-title":"Abridged geriatric assessment is a better predictor of overall survival than the Karnofsky Performance Scale and Physical Performance Test in elderly patients with cancer","volume":"8","author":"Ghosn","year":"2017","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.012_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1634\/theoncologist.2014-0247","article-title":"Geriatric assessment-identified deficits in older cancer patients with normal performance status","volume":"20","author":"Jolly","year":"2015","journal-title":"Oncologist"},{"issue":"21","key":"10.1016\/j.ejca.2022.12.012_bib26","doi-asserted-by":"crossref","first-page":"24192","DOI":"10.18632\/aging.203673","article-title":"Association of frailty and chemotherapy-related adverse outcomes in geriatric patients with cancer: a pilot observational study in Taiwan","volume":"13","author":"Ho","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.ejca.2022.12.012_bib27","doi-asserted-by":"crossref","first-page":"e740","DOI":"10.1200\/OP.20.00681","article-title":"Predictors of unplanned hospitalizations among older adults receiving cancer chemotherapy","volume":"17","author":"Klepin","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"10.1016\/j.ejca.2022.12.012_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1200\/JOP.2015.004812","article-title":"ReCAP: hospitalizations in older adults with advanced cancer: the role of chemotherapy","volume":"12","author":"O'Neill","year":"2016","journal-title":"J Oncol Pract"},{"issue":"1","key":"10.1016\/j.ejca.2022.12.012_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.breast.2013.11.004","article-title":"Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group","volume":"23","author":"Hamaker","year":"2014","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.ejca.2022.12.012_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clbc.2018.10.002","article-title":"A phase II trial of older adults with metastatic breast cancer receiving nab-paclitaxel: melding the fields of geriatrics and oncology","volume":"19","author":"Hurria","year":"2019","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2022.12.012_bib31","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jgo.2020.11.004","article-title":"Unplanned hospitalizations in older patients with cancer: occurrence and predictive factors","volume":"12","author":"Lodewijckx","year":"2021","journal-title":"J Geriatr Oncol"},{"issue":"9829","key":"10.1016\/j.ejca.2022.12.012_bib32","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejca.2022.12.012_bib33","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1186\/s12885-019-5988-3","article-title":"Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses","volume":"19","author":"Cesne","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2022.12.012_bib34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000518162","article-title":"Prognostic impact of trial-eligibility criteria in patients with metastatic renal cell carcinoma","volume":"106","author":"Ishihara","year":"2022","journal-title":"Urol Int"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922018147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922018147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:40:59Z","timestamp":1760733659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922018147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":34,"alternative-id":["S0959804922018147"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.12.012","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}